Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127236051 | 12723605 | 1 | I | 20160812 | 20160819 | 20160908 | 20160908 | EXP | US-BAXTER-2016BAX044172 | BAXTER | 57.84 | YR | F | Y | 41.00000 | KG | 20160908 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127236051 | 12723605 | 1 | PS | DIANEAL LOW CALCIUM PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE | CALCIUM CHLORIDEDEXTROSEMAGNESIUM CHLORIDESODIUM CHLORIDESODIUM LACTATE | 1 | Intraperitoneal | 20183 | 1.5 | L | SOLUTION FOR PERITONEAL DIALYSIS | ||||||||
| 127236051 | 12723605 | 2 | SS | ATIVAN | LORAZEPAM | 1 | Intravenous (not otherwise specified) | EVERY 2 HOURS | U | 0 | 1 | MG | INJECTION | ||||||
| 127236051 | 12723605 | 3 | SS | ATIVAN | LORAZEPAM | 1 | Oral | EVERY 1 HOUR | U | 0 | .5 | MG | |||||||
| 127236051 | 12723605 | 4 | SS | CHLORASEPTIC SORE THROAT | PHENOL | 1 | Oral | 1 LOZ EVERY ONE HOUR | U | 0 | LOZENGE | ||||||||
| 127236051 | 12723605 | 5 | SS | MORPHINE | MORPHINE | 1 | Intravenous (not otherwise specified) | IV PCA (CONTINUOUS) | U | 0 | 30 | MG | |||||||
| 127236051 | 12723605 | 6 | SS | NARCAN | NALOXONE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | EVERY TWO MINTUES | U | 0 | .1 | MG | |||||||
| 127236051 | 12723605 | 7 | SS | RESTORIL | TEMAZEPAM | 1 | Oral | EVERY NIGHT AT BEDTIME AS REQUIRED | U | 0 | 15 | MG | |||||||
| 127236051 | 12723605 | 8 | SS | ROXANOL | MORPHINE SULFATE | 1 | Oral | EVERY ONE HOUR | U | 0 | 5 | MG | |||||||
| 127236051 | 12723605 | 9 | SS | TRANSDERM SCOP | SCOPOLAMINE | 1 | Transdermal | 1 PATCH EVERY 72 HOURS | U | 0 | TRANSDERMAL PATCH | ||||||||
| 127236051 | 12723605 | 10 | SS | XANAX | ALPRAZOLAM | 1 | Oral | EVERY 6 HOURS | U | 0 | .25 | MG | |||||||
| 127236051 | 12723605 | 11 | C | APRESOLINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | EVERY 1 HOUR | 0 | 10 | MG | INJECTION | |||||||
| 127236051 | 12723605 | 12 | C | ATROPINE. | ATROPINE | 1 | Unknown | 2 DROPS | 0 | EYE DROPS | |||||||||
| 127236051 | 12723605 | 13 | C | DULCOLAX NOS | BISACODYL OR DOCUSATE SODIUM | 1 | Rectal | ONCE DAILY AS REQUIRED | 0 | 10 | MG | SUPPOSITORY | |||||||
| 127236051 | 12723605 | 14 | C | MAALOX ANTACID | ALUMINUM HYDROXIDEDIMETHICONEMAGNESIUM HYDROXIDE | 1 | Oral | EVERY FOUR HOUR | 0 | ||||||||||
| 127236051 | 12723605 | 15 | C | MILK OF MAGNESIA | MAGNESIUM HYDROXIDE | 1 | Oral | ONCE | 0 | ||||||||||
| 127236051 | 12723605 | 16 | C | OCEAN/DEEP SEA | 2 | Nasal | 1 SPRAY EVERY ONE HOUR | 0 | NASAL SPRAY | ||||||||||
| 127236051 | 12723605 | 17 | C | SENOKOT-S | DOCUSATE SODIUMSENNOSIDES | 1 | Oral | 1 TABLET 2TIMES DAILY, AS REQUIRED | 0 | TABLET | BID | ||||||||
| 127236051 | 12723605 | 18 | C | TYLENOL | ACETAMINOPHEN | 1 | Rectal | EVERY 4 HOURS | 0 | 650 | MG | SUPPOSITORY | |||||||
| 127236051 | 12723605 | 19 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | EVERY 6 HOURS | 0 | 4 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127236051 | 12723605 | 1 | Peritoneal dialysis |
| 127236051 | 12723605 | 2 | Product used for unknown indication |
| 127236051 | 12723605 | 4 | Product used for unknown indication |
| 127236051 | 12723605 | 5 | Product used for unknown indication |
| 127236051 | 12723605 | 6 | Product used for unknown indication |
| 127236051 | 12723605 | 7 | Product used for unknown indication |
| 127236051 | 12723605 | 8 | Product used for unknown indication |
| 127236051 | 12723605 | 9 | Product used for unknown indication |
| 127236051 | 12723605 | 10 | Product used for unknown indication |
| 127236051 | 12723605 | 11 | Product used for unknown indication |
| 127236051 | 12723605 | 12 | Product used for unknown indication |
| 127236051 | 12723605 | 13 | Product used for unknown indication |
| 127236051 | 12723605 | 14 | Product used for unknown indication |
| 127236051 | 12723605 | 15 | Product used for unknown indication |
| 127236051 | 12723605 | 16 | Product used for unknown indication |
| 127236051 | 12723605 | 17 | Product used for unknown indication |
| 127236051 | 12723605 | 18 | Product used for unknown indication |
| 127236051 | 12723605 | 19 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127236051 | 12723605 | DE |
| 127236051 | 12723605 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127236051 | 12723605 | Acute respiratory failure | |
| 127236051 | 12723605 | Cognitive disorder | |
| 127236051 | 12723605 | Death | |
| 127236051 | 12723605 | Hypersomnia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127236051 | 12723605 | 1 | 20160816 | 0 |